메뉴 건너뛰기




Volumn 19, Issue 5, 2009, Pages 527-533

Assessment and proposal of a new combination of screening criteria for hepatitis C in France

Author keywords

France; Hepatitis C; Risk factors; Screening

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; ILLICIT DRUG;

EID: 70349495350     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckp112     Document Type: Article
Times cited : (8)

References (35)
  • 1
    • 0030912791 scopus 로고    scopus 로고
    • Hepatitis C in a French population-based survey 1994: Seroprevalence, frequency of viremia, genotype distribution, and risk factors
    • and the collaborative study group
    • Dubois F, Desenclos JC, Mariotte N, Goudeau A and the collaborative study group. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. Hepatology 1997;25:1490-1496
    • (1997) Hepatology , vol.25 , pp. 1490-1496
    • Dubois, F.1    Desenclos, J.C.2    Mariotte, N.3    Goudeau, A.4
  • 2
    • 34547650038 scopus 로고    scopus 로고
    • Screening and treatment of hepatitis C. Consensus conference of the 16 and 17 January 1997
    • Agence Nationale d'Accréditation et d'Evaluation en Santé, Association Française du Foie, Société Nationale Française de Gastro-entérologie. Dépistage et traitement de l'hépatite C. Conférence de consensus des 16 et 17 janvier 1997
    • Agence Nationale d'Accréditation et d'Evaluation en Santé, Association Française du Foie, Société Nationale Française de Gastro-entérologie. Dépistage et traitement de l'hépatite C. Conférence de consensus des 16 et 17 janvier 1997 (Screening and treatment of hepatitis C. Consensus conference of the 16 and 17 January 1997). Gastroenterol Clin Biol 1997;21:45-55.
    • (1997) Gastroenterol Clin Biol , vol.21 , pp. 45-55
  • 4
    • 84869628720 scopus 로고    scopus 로고
    • Prévalence des hépatites B et C en France en 2004
    • (4 March 2009, date last accessed).
    • Meffre C, Le Strat Y, Delarocque-Astagneau E, et al. Prévalence des hépatites B et C en France en 2004 (prevalence of hepatitis B and C in France in 2004). InVS, Saint-Maurice, 2007: http://www.invs.sante.fr/ publications/2006/prevalence-b-c/vhb-france-2004.pdf (4 March 2009, date last accessed).
    • (2007) InVS, Saint-Maurice
    • Meffre, C.1    Le Strat, Y.2    Delarocque-Astagneau, E.3
  • 6
    • 0030946469 scopus 로고    scopus 로고
    • Analysis of targeted screening strategies for hepatitis C infection
    • Analyse des stratégies de dépistage orienté de l'infection par le virus de l'hépatite
    • Desenclos JC, Dubois F, Mariotte N, Goudeau A. Analyse des stratégies de dépistage orienté de l'infection par le virus de l'hépatite (Analysis of targeted screening strategies for hepatitis C infection). Gastroenterol Clin Biol 1997;21:S25-32.
    • (1997) Gastroenterol Clin Biol , vol.21
    • Desenclos, J.C.1    Dubois, F.2    Mariotte, N.3    Goudeau, A.4
  • 7
    • 0031557268 scopus 로고    scopus 로고
    • World Health Organisation
    • World Health Organisation. Hepatitis C. Wkly Epidemiol Record 1997;72:65-69
    • (1997) Wkly Epidemiol Record , vol.72 , pp. 65-69
    • Hepatitis, C.1
  • 9
    • 0020083498 scopus 로고
    • The meaning and use of the area under a receiver operating characteristic (ROC) curve
    • Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
    • (1982) Radiology , vol.143 , pp. 29-36
    • Hanley, J.A.1    McNeil, B.J.2
  • 10
    • 0025756235 scopus 로고
    • The use of ROC curves and their analysis
    • Centor MD. The use of ROC curves and their analysis. Med Decis Making 1991;11:102-106
    • (1991) Med Decis Making , vol.11 , pp. 102-106
    • Centor, M.D.1
  • 11
    • 0034906866 scopus 로고    scopus 로고
    • Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis
    • Steyerberg EW, Harrell FE, Borsboom GJ, et al. Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001;54:774-781
    • (2001) J Clin Epidemiol , vol.54 , pp. 774-781
    • Steyerberg, E.W.1    Harrell, F.E.2    Borsboom, G.J.3
  • 12
    • 0033574245 scopus 로고    scopus 로고
    • Assessing the generalizability of prognostic information
    • Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med 1999;130:515-524
    • (1999) Ann Intern Med , vol.130 , pp. 515-524
    • Justice, A.C.1    Covinsky, K.E.2    Berlin, J.A.3
  • 13
    • 0030069896 scopus 로고    scopus 로고
    • Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
    • Harrell FE, Kerry KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-387
    • (1996) Stat Med , vol.15 , pp. 361-387
    • Harrell, F.E.1    Kerry, K.L.2    Mark, D.B.3
  • 14
    • 0034728356 scopus 로고    scopus 로고
    • What do we mean by validating a prognostic model?
    • Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med 2000;19:453-473
    • (2000) Stat Med , vol.19 , pp. 453-473
    • Altman, D.G.1    Royston, P.2
  • 15
    • 1842289823 scopus 로고    scopus 로고
    • Resampling and cross-validation techniques: A tool to reduce bias caused by model building
    • Schumacher M, Holländer N, Sauerbrei W. Resampling and cross-validation techniques: A tool to reduce bias caused by model building. Stat Med 1997;16:2813-2827
    • (1997) Stat Med , vol.16 , pp. 2813-2827
    • Schumacher, M.1    Holländer, N.2    Sauerbrei, W.3
  • 16
    • 11144288616 scopus 로고    scopus 로고
    • Penalized maximum likelihood estimation to directly adjust diagnostic and prognostic prediction models for overoptimism
    • Moons KGM, Donders ART, Steyerberg EW, Harrell FE. Penalized maximum likelihood estimation to directly adjust diagnostic and prognostic prediction models for overoptimism. J Clin Epidemiol 2004;57:1262-1270
    • (2004) J Clin Epidemiol , vol.57 , pp. 1262-1270
    • Moons, K.G.M.1    Donders, A.R.T.2    Steyerberg, E.W.3    Harrell, F.E.4
  • 17
    • 0025151933 scopus 로고
    • Predictive value of statistical models
    • van Howelingen JC, Le Cessie S. Predictive value of statistical models. Stat Med 1990;9:1303-1325
    • (1990) Stat Med , vol.9 , pp. 1303-1325
    • Van Howelingen, J.C.1    Le Cessie, S.2
  • 21
    • 33745907392 scopus 로고    scopus 로고
    • A casecontrol study of risk factors for hepatitis C infection in patients with unexplained routes of infection
    • Karmochkine M, Carrat F, Dos Santos O, et al. A casecontrol study of risk factors for hepatitis C infection in patients with unexplained routes of infection. J Viral Hepat 2006;13:775-782
    • (2006) J Viral Hepat , vol.13 , pp. 775-782
    • Karmochkine, M.1    Carrat, F.2    Dos Santos, O.3
  • 22
    • 34548545216 scopus 로고    scopus 로고
    • An incident case- co ntrol study of modes of Hepatitis C virus transmission in France
    • Delarocque-Astagneau E, Pillonel J, De Valk H, et al. An incident case- co ntrol study of modes of Hepatitis C virus transmission in France. Ann Epidemiol 2007;17:755-762
    • (2007) Ann Epidemiol , vol.17 , pp. 755-762
    • Delarocque-Astagneau, E.1    Pillonel, J.2    De Valk, H.3
  • 23
    • 17444417852 scopus 로고    scopus 로고
    • Modeling sources of self-report bias in a survey of drug use epidemiology
    • Johnson T, Fendrich M. Modeling sources of self-report bias in a survey of drug use epidemiology. Ann Epidemiol 2005;15:381-389
    • (2005) Ann Epidemiol , vol.15 , pp. 381-389
    • Johnson, T.1    Fendrich, M.2
  • 24
    • 15844389654 scopus 로고    scopus 로고
    • Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection
    • Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996;334:1691-1696
    • (1996) N Engl J Med , vol.334 , pp. 1691-1696
    • Conry-Cantilena, C.1    Vanraden, M.2    Gibble, J.3
  • 25
    • 33646852746 scopus 로고    scopus 로고
    • The prevalence of hepatitis C virus infection in the United States 1999-2002
    • Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999-200 2. Ann Intern Med 2006;144:705-715
    • (2006) Ann Intern Med , vol.144 , pp. 705-715
    • Armstrong, G.L.1    Wasley, A.2    Simard, E.P.3
  • 26
    • 0033584440 scopus 로고    scopus 로고
    • The prevalence of hepatitis C virus infection in the United States 1988 through 1994
    • Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-562
    • (1999) N Engl J Med , vol.341 , pp. 556-562
    • Alter, M.J.1    Kruszon-Moran, D.2    Nainan, O.V.3
  • 27
    • 0036267792 scopus 로고    scopus 로고
    • Risk factors for hepatitis C virus infection among homeless adults
    • Nyamathi AM, Dixon EL, Robbins W, et al. Risk factors for hepatitis C virus infection among homeless adults. J Gen Intern Med 2002;17:134-143
    • (2002) J Gen Intern Med , vol.17 , pp. 134-143
    • Nyamathi, A.M.1    Dixon, E.L.2    Robbins, W.3
  • 28
    • 84869615509 scopus 로고    scopus 로고
    • Study of those receiving the medical welfare for precarious individuals (November 2000), principle results
    • Enquête aupres des bénéficiaires de la CMU (novembre 2000), principaux résultats. Document de travail. Paris: Ministere des affaires sociales, du travail et de la solidarité, Ministere de la santé, de la famille et des personnes handicapées; (4 March 2009, date last accessed)
    • Boisguérin B. Enquête aupres des bénéficiaires de la CMU (novembre 2000), principaux résultats [Study of those receiving the medical welfare for precarious individuals (November 2000), principle results]. Série statistiques, no 41. Document de travail. Paris: Ministere des affaires sociales, du travail et de la solidarité, Ministere de la santé, de la famille et des personnes handicapées; 2002: http://www.sante.gouv.fr/drees/seriestat/pdf/ seriestat41.pdf (4 March 2009, date last accessed).
    • (2002) Série Statistiques, No 41
    • Boisguérin, B.1
  • 29
    • 2542418209 scopus 로고    scopus 로고
    • Efficiency of hepatitis C virus screening strategies in general practice
    • Josset V, Torre JP, Tavolacci MP, et al. Efficiency of hepatitis C virus screening strategies in general practice. Gastroenterol Clin Biol 2004;28:351-357
    • (2004) Gastroenterol Clin Biol , vol.28 , pp. 351-357
    • Josset, V.1    Torre, J.P.2    Tavolacci, M.P.3
  • 30
    • 0037320914 scopus 로고    scopus 로고
    • Nosocomial transmission of hepatitis C virus associated with the use of multidose saline vials
    • Krause G, Trepka MJ, Whisenhunt RS, et al. Nosocomial transmission of hepatitis C virus associated with the use of multidose saline vials. Infect Control Hosp Epidemiol 2003;24:122-127
    • (2003) Infect Control Hosp Epidemiol , vol.24 , pp. 122-127
    • Krause, G.1    Trepka, M.J.2    Whisenhunt, R.S.3
  • 31
    • 25644454314 scopus 로고    scopus 로고
    • Patient-to-patient transmission of hepatitis C virus through the use of multidose vials during general anesthesia
    • Germain JM, Carbonne A, Thiers V, et al. Patient-to-patient transmission of hepatitis C virus through the use of multidose vials during general anesthesia. Infect Control Hosp Epidemiol 2005;26:789-792
    • (2005) Infect Control Hosp Epidemiol , vol.26 , pp. 789-792
    • Germain, J.M.1    Carbonne, A.2    Thiers, V.3
  • 32
    • 33847036602 scopus 로고    scopus 로고
    • Viability of the area under the receiver operating characteristic curve in the diagnostic evaluation of liver fibrosis markers: Impact of biopsy length and fragmentation
    • Poynard T, Halfon P, Castera L, et al. Viability of the area under the receiver operating characteristic curve in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Aliment Pharmacol Ther 2007;25:733-739
    • (2007) Aliment Pharmacol Ther , vol.25 , pp. 733-739
    • Poynard, T.1    Halfon, P.2    Castera, L.3
  • 33
    • 54049153227 scopus 로고    scopus 로고
    • Validation of a hepatitis C screening tool in primary care
    • McGinn T, O-Connor-Moore N, Alfandre D, et al. Validation of a hepatitis C screening tool in primary care. Arch Intern Med 2008;168:2009-2013
    • (2008) Arch Intern Med , vol.168 , pp. 2009-2013
    • McGinn, T.1    O-Connor-Moore, N.2    Alfandre, D.3
  • 34
    • 33744782841 scopus 로고    scopus 로고
    • Prediction of Chlamydia trachomatis infection: Application of a scoring rule to other populations
    • Götz HM, Veldhuijzen IK, Habbema JD, et al. Prediction of Chlamydia trachomatis infection: Application of a scoring rule to other populations. Sex Transm Dis 2006;33:374-380
    • (2006) Sex Transm Dis , vol.33 , pp. 374-380
    • Götz, H.M.1    Veldhuijzen, I.K.2    Habbema, J.D.3
  • 35
    • 0036829816 scopus 로고    scopus 로고
    • Natural history of chronic hepatitis C
    • Seef LB. Natural history of chronic hepatitis C. Hepatology 2002;36:S35-46.
    • (2002) Hepatology , vol.36
    • Seef, L.B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.